BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2907593)

  • 1. Inhibitory effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in the caudate nucleus.
    Hirose A; Sasa M; Ohno Y; Takaori S
    Jpn J Pharmacol; 1988 Dec; 48(4):435-40. PubMed ID: 2907593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in spinal trigeminal nucleus.
    Sasa M; Ohno Y; Nabatame H; Yoshimura N; Takaori S
    Brain Res; 1987 Sep; 420(1):157-61. PubMed ID: 3119149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
    Kato T; Katsuyama M; Karai N; Hirose A; Nakamura M; Katsube J
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):243-6. PubMed ID: 3086752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
    Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
    Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-threo-DOPS, a noradrenaline precursor, on the long-term potentiation in the rat hippocampal mossy fiber-CA3 region.
    Sakai N; Sasa M; Ishihara K; Komure O; Tanaka C; Takaori S
    Brain Res; 1991 Dec; 567(2):267-73. PubMed ID: 1817730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition from locus coeruleus of caudate neurons activated by nigral stimulation.
    Fujimoto S; Sasa M; Takaori S
    Brain Res Bull; 1981 Mar; 6(3):267-74. PubMed ID: 7225906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons.
    Ohno Y; Sasa M; Takaori S
    Life Sci; 1987 May; 40(19):1937-45. PubMed ID: 3553819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
    Man in 't Veld AJ; Boomsma F; van den Meiracker AH; Julien C; Lenders J; Schalekamp MA
    J Hypertens Suppl; 1988 Dec; 6(4):S547-9. PubMed ID: 3149290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
    Sato E; Irie T; Katsube J
    Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-threo-3,4-dihydroxyphenylserine enhanced ocular dominance plasticity in adult cats.
    Mataga N; Imamura K; Watanabe Y
    Neurosci Lett; 1992 Aug; 142(2):115-8. PubMed ID: 1454203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic inhibition of excitatory input from the substantia nigra to caudate nucleus neurons by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392).
    Sasa M; Ohno Y; Takaori S
    Life Sci; 1988; 43(3):263-9. PubMed ID: 3398698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of DL-erythro-dihydroxyphenylserine on the locomotor activity of the mouse.
    Mori T; Nakajima T; Hashimoto H; Noto T; Kato N
    Pharmacol Biochem Behav; 1985 Jun; 22(6):979-83. PubMed ID: 2862644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
    J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
    Semba J; Takahashi R
    Psychiatry Res; 1985 Aug; 15(4):319-26. PubMed ID: 3934694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus coeruleus-induced inhibition of dorsal cochlear nucleus neurons in comparison with lateral vestibular nucleus neurons.
    Chikamori Y; Sasa M; Fujimoto S; Takaori S; Matsuoka I
    Brain Res; 1980 Jul; 194(1):53-63. PubMed ID: 7378847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in the chronotropic effect and the enzymic decarboxylation of L-threo-3,4-dihydroxphenylserine in the rat heart.
    Araki H; Fujiwara H; Tanaka C
    J Pharm Pharmacol; 1981 Dec; 33(12):778-82. PubMed ID: 6121849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A noradrenaline-induced inhibition from locus coeruleus of nucleus accumbens neuron receiving input from hippocampus.
    Unemoto H; Sasa M; Takaori S
    Jpn J Pharmacol; 1985 Oct; 39(2):233-9. PubMed ID: 4087568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.